General - Press Releases

Date	Title	Company
17-Apr-2023	Global Membrane Market Report 2022: Sector is Expected to Reach $49.25 Billion by 2028 at a CAGR of 12.2% - ResearchAndMarkets.com	Businesswire
17-Apr-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
17-Apr-2023	Genmab and argenx Enter Partnership to Advance Antibody Therapies in Immunology and Oncology	Businesswire
17-Apr-2023	Transgene - Preclinical Results Showing TG6050, a Novel Oncolytic Virus, induces Tumor Regression by Activating Innate and Adaptive immune responses presented at AACR	Businesswire
17-Apr-2023	Pherecydes Pharma presented at the ECCMID congress an analytical performance protocol demonstrating the compliance of its Phagogram 1.5 with regulatory requirements	Businesswire
17-Apr-2023	ECCMID 2023: Shionogi Announces Real-World Evidence Demonstrating the Efficacy of Fetcroja® (cefiderocol) Against Some of the Most Difficult-to-Treat Gram-Negative Bacterial Pathogens	Businesswire
17-Apr-2023	Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Alzheimer’s Dementia	Businesswire
16-Apr-2023	Preclinical Data on Volastra Therapeutics’ Two Novel and Differentiated KIF18A Inhibitors Presented at AACR 2023	Businesswire
16-Apr-2023	Genentech’s Tecentriq Plus Avastin Reduced the Risk of Cancer Returning in People With Certain Types of Adjuvant Liver Cancer in a Phase III Study	Businesswire
16-Apr-2023	Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.	Businesswire
15-Apr-2023	Pandemic Accord Must Keep IP Waiver Provisions, says AHF	Businesswire
15-Apr-2023	EUROAPI: Availability of the 2022 Universal Registration Document, Including the Annual Financial Report	Businesswire
14-Apr-2023	MEI Pharma Announces 1-for-20 Reverse Stock Split	Businesswire
14-Apr-2023	Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023	Businesswire
14-Apr-2023	Sensient Announces Conference Call	Businesswire
14-Apr-2023	Rapid Dose Announces Filing of Corrective Disclosure	Businesswire
14-Apr-2023	China Must Ensure Safety Is Paramount in Biotech Push, says AHF	Businesswire
14-Apr-2023	Rapid Dose Announces Board of Director Changes	Businesswire
14-Apr-2023	Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics	Businesswire
14-Apr-2023	MiNA Therapeutics Presents Late-Breaking Positive Phase 1b Data for MTL-CEBPA in Combination with an Anti-PD1 Checkpoint Inhibitor at the Annual American Association of Cancer Research (AACR) Meeting	Businesswire